Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks
- The Congo will receive 70,000 doses of the Ervebo Ebola vaccine for trials and limited use against the Bundibugyo strain, according to the WHO.
- Among these doses, 20,000 are allocated for a Phase 3 clinical trial studying the vaccine's effect on the Bundibugyo virus, while 50,000 are reserved for frontline and health workers.
- The Democratic Republic of Congo's 17th Ebola outbreak was declared on May 15 and had likely been spreading for several weeks before that declaration.
- WHO experts have recommended a full-scale trial of Ervebo to test possible cross-protection against the Bundibugyo strain based on early lab and animal data.
16 Articles
16 Articles
News quickly and reliably.
The Democratic Republic of Congo (DRC) is receiving 70,000 doses of a vaccine against the Ebola virus, the World Health Organization (WHO) reports. There is currently no approved vaccine for the variant of the virus currently circulating in the African country.
Congo to receive 70,000 doses of Ervebo Ebola vaccine, which has been effective in past outbreaks
Congo will receive 70,000 doses of the Ervebo vaccine, which has been effective in past Ebola outbreaks, the World Health Organization and partners said Thursday, announcing a step seen as a major boost to efforts to contain what officials have described as the fastest Ebola outbreak in history.
Congo gets 70,000 Ervebo doses as Ebola outbreak surges
Congo is set to receive 70,000 Ervebo vaccine doses as officials battle a fast-moving Ebola outbreak. The shipment could strengthen frontline protection while researchers test whether it works against the Bundibugyo virus.
Congo to receive 70,000 Ebola vaccine doses as authorities battle fast-spreading outbreak
Congo to receive 70,000 Ervebo Ebola vaccine doses to protect frontline workers and support a Phase III trial as authorities battle the fastest-spreading outbreak linked to the Bundibugyo virus
Coverage Details
Bias Distribution
- 38% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
